Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

SABSSABS
Showing 8 of 19 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in SAB BIOTHERAPEUTICS INC

GEODE CAPITAL MANAGEMENT, LLC holds 1.3M shares of SABS (SAB BIOTHERAPEUTICS INC), worth $5M as of 2026-Q2. The position was increased (+322.9% shares). SABS represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$5M

Current Shares

1.3M

Total Value Change

+$4.8M

Total Shares Change

+1.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.3M
+322.9%
$5M0.0%$3.90
43
2026-Q1
Increased
302,036
+152.7%
$1.2M0.0%$3.89
41
2025-Q4
Increased
119,517
+39.4%
$447,0370.0%$3.77
22
2025-Q3
Increased
85,718
+1.1%
$172,3170.0%$1.95
16
2025-Q2
Increased
84,772
+0.1%
$148,3710.0%$1.69
15
2025-Q1
Increased
84,685
+5.5%
$114,3420.0%$1.48
16
2024-Q4
Increased
80,234
+18.8%
$306,5470.0%$4.15
19
2024-Q3
Increased
67,542
+13.7%
$182,3930.0%$2.57
18

Other major holders of SABS: ADAGE CAPITAL PARTNERS GP, L.L.C., RA CAPITAL MANAGEMENT, L.P., BALYASNY ASSET MANAGEMENT L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used